CII
TMO icon

Capital International Inc’s Thermo Fisher Scientific TMO Stock Holding History

Capital International Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5M Sell
70,786
-13,045
-16% -$6.26M 0.25% 103
2026
Q1 		$41.2M Sell
83,831
-9,981
-11% -$5.42M 0.32% 85
2025
Q4 		$54.4M Buy
93,812
+3,502
+4% +$1.98M 0.43% 54
2025
Q3 		$43.8M Buy
90,310
+23,811
+36% +$11.1M 0.35% 79
2025
Q2 		$27M Buy
66,499
+6,271
+10% +$2.62M 0.26% 107
2025
Q1 		$30M Buy
60,228
+13,462
+29% +$7.29M 0.36% 83
2024
Q4 		$24.3M Buy
46,766
+3,729
+9% +$2.05M 0.29% 101
2024
Q3 		$26.6M Buy
43,037
+232
+0.5% +$137K 0.34% 84
2024
Q2 		$23.7M Sell
42,805
-6,790
-14% -$3.89M 0.31% 90
2024
Q1 		$28.8M Buy
49,595
+7,294
+17% +$4.09M 0.39% 75
2023
Q4 		$22.5M Buy
42,301
+4,293
+11% +$2.08M 0.35% 91
2023
Q3 		$19.2M Buy
38,008
+3,783
+11% +$2.02M 0.37% 86
2023
Q2 		$17.9M Buy
34,225
+6,002
+21% +$3.24M 0.32% 92
2023
Q1 		$16.3M Sell
28,223
-431
-2% -$243K 0.33% 95
2022
Q4 		$15.8M Sell
28,654
-408
-1% -$216K 0.34% 90
2022
Q3 		$14.7M Sell
29,062
-11,465
-28% -$6.42M 0.33% 95
2022
Q2 		$22M Sell
40,527
-274
-0.7% -$151K 0.31% 112
2022
Q1 		$24.1M Sell
40,801
-14,357
-26% -$8.25M 0.27% 115
2021
Q4 		$36.8M Buy
55,158
+1,074
+2% +$671K 0.34% 95
2021
Q3 		$30.9M Sell
54,084
-4,459
-8% -$2.45M 0.3% 101
2021
Q2 		$29.5M Sell
58,543
-1,040
-2% -$491K 0.26% 116
2021
Q1 		$27.2M Sell
59,583
-3,430
-5% -$1.64M 0.25% 118
2020
Q4 		$29.4M Buy
63,013
+3,181
+5% +$1.49M 0.27% 111
2020
Q3 		$26.4M Sell
59,832
-6,687
-10% -$2.76M 0.29% 107
2020
Q2 		$24.1M Buy
66,519
+25,454
+62% +$8.53M 0.29% 110
2020
Q1 		$11.6M Buy
+41,065
New +$12.9M 0.2% 108
2019
Q3 		– Sell
-20,724
Closed -$6.09M – 243
2019
Q2 		$6.09M Buy
+20,724
New +$5.71M 0.43% 70

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Inc's TMO Position: Q2 2026 in Review

Capital International Inc reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, selling an estimated $6.26M and leaving 70,786 shares worth $35.5M. The position accounts for 0.25% of the portfolio, ranked #103.

Capital International Inc first reported a position in TMO in Q2 2019 and has held it in 27 quarters since. The position peaked at $54.4M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital International Inc held 70,786 shares of Thermo Fisher Scientific worth $35.5M as of Q2 2026.
  • Capital International Inc sold 13,045 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.26M.
  • Thermo Fisher Scientific made up 0.25% of Capital International Inc's portfolio in Q2 2026, its #103 holding.
  • Capital International Inc first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 27 quarters since.
  • Capital International Inc's Thermo Fisher Scientific position peaked at $54.4M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.